Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Mouth Neoplasms × dacomitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mouth Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 4 Radiotherapy 2 Paclitaxel 2 tozuleristide 1 pembrolizumab 1 niraparib 1 dostarlimab 1 dacomitinib 1 advexin 1 Taxes 1 Sirolimus 1 Pemetrexed 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Chemoprevention 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01116843 2015-07-10

Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment

University Health Network, Toronto

Phase 1/2 Completed

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡